Richard Gliklich BA ’83 is CEO of OM1, a data, outcomes and technology company focused on organizing health information to support medical research, outcomes measurement and personalized medicine, especially for chronic diseases. Dr. Gliklich is also the Leffenfeld Professor, part-time, in the Department of Otolaryngology at Harvard Medical School and Massachusetts Eye and Ear where he has been a surgeon on the faculty since completing his training. Prior to OM1, Dr. Gliklich was an executive in residence with General Catalyst Partners focused on investments in healthcare companies. Previously, he was founder and CEO of Outcome, which he led from inception through its acquisition by Quintiles. Dr. Gliklich is well known in the areas of registries, outcomes and analytics. He is senior editor of the landmark publication by the U.S. Agency for Healthcare Research and Quality (AHRQ) handbook "Registries for Evaluating Patient Outcomes: A User's Guide” and leads the Outcomes Measures Framework, which focuses on standardization of outcomes measurement.Dr. Gliklich holds patents in medical outcomes systems and medical devices. He received his B.A. from Yale University (Summa Cum Laude) and his M.D. from Harvard Medical School.
Education & Training
- MDHarvard Medical School (1988)